CA1337177C - Bioparyl, a biological regulator, active against various pathologies - Google Patents
Bioparyl, a biological regulator, active against various pathologiesInfo
- Publication number
- CA1337177C CA1337177C CA000603639A CA603639A CA1337177C CA 1337177 C CA1337177 C CA 1337177C CA 000603639 A CA000603639 A CA 000603639A CA 603639 A CA603639 A CA 603639A CA 1337177 C CA1337177 C CA 1337177C
- Authority
- CA
- Canada
- Prior art keywords
- bioparyl
- mammal
- fibrosis
- activity
- globulins
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000007170 pathology Effects 0.000 title 1
- 102000006382 Ribonucleases Human genes 0.000 claims abstract 8
- 108010083644 Ribonucleases Proteins 0.000 claims abstract 8
- 230000000694 effects Effects 0.000 claims abstract 6
- 206010016654 Fibrosis Diseases 0.000 claims abstract 5
- 230000004761 fibrosis Effects 0.000 claims abstract 5
- 206010028980 Neoplasm Diseases 0.000 claims abstract 4
- 108060003951 Immunoglobulin Proteins 0.000 claims abstract 3
- 241001465754 Metazoa Species 0.000 claims abstract 3
- 108010074605 gamma-Globulins Proteins 0.000 claims abstract 3
- 102000018358 immunoglobulin Human genes 0.000 claims abstract 3
- 229940072221 immunoglobulins Drugs 0.000 claims abstract 3
- 230000005855 radiation Effects 0.000 claims abstract 3
- 208000023275 Autoimmune disease Diseases 0.000 claims abstract 2
- 244000194101 Ginkgo biloba Species 0.000 claims abstract 2
- 210000004072 lung Anatomy 0.000 claims abstract 2
- 241000124008 Mammalia Species 0.000 claims 7
- 201000011510 cancer Diseases 0.000 claims 3
- 230000018109 developmental process Effects 0.000 claims 3
- 229940079593 drug Drugs 0.000 claims 3
- 239000003814 drug Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims 2
- 230000002159 abnormal effect Effects 0.000 claims 2
- 230000002255 enzymatic effect Effects 0.000 claims 2
- 230000002401 inhibitory effect Effects 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 239000006228 supernatant Substances 0.000 claims 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 2
- 241000725303 Human immunodeficiency virus Species 0.000 claims 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims 1
- 206010050207 Skin fibrosis Diseases 0.000 claims 1
- 238000005903 acid hydrolysis reaction Methods 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000011712 cell development Effects 0.000 claims 1
- 238000004440 column chromatography Methods 0.000 claims 1
- 239000002552 dosage form Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 229910052742 iron Inorganic materials 0.000 claims 1
- 201000005202 lung cancer Diseases 0.000 claims 1
- 208000020816 lung neoplasm Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 238000006386 neutralization reaction Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 208000005069 pulmonary fibrosis Diseases 0.000 claims 1
- 230000003612 virological effect Effects 0.000 claims 1
- 208000030507 AIDS Diseases 0.000 abstract 2
- 108090000790 Enzymes Proteins 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 238000002512 chemotherapy Methods 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 230000014509 gene expression Effects 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 208000027866 inflammatory disease Diseases 0.000 abstract 1
- 230000002757 inflammatory effect Effects 0.000 abstract 1
- 208000032839 leukemia Diseases 0.000 abstract 1
- 230000001717 pathogenic effect Effects 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
- 238000001959 radiotherapy Methods 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 208000011580 syndromic disease Diseases 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
- Compounds Of Unknown Constitution (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR8809738A FR2634380B1 (fr) | 1988-07-19 | 1988-07-19 | Regulateur biologique, actif dans diverses pathologies |
| FR8809738 | 1988-07-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1337177C true CA1337177C (en) | 1995-10-03 |
Family
ID=9368543
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA000603639A Expired - Fee Related CA1337177C (en) | 1988-07-19 | 1989-06-22 | Bioparyl, a biological regulator, active against various pathologies |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0352146B1 (enExample) |
| JP (1) | JPH0278628A (enExample) |
| CA (1) | CA1337177C (enExample) |
| DE (1) | DE68903065T2 (enExample) |
| DK (1) | DK355089A (enExample) |
| ES (1) | ES2052942T3 (enExample) |
| FR (1) | FR2634380B1 (enExample) |
| GR (1) | GR3006687T3 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3832056A1 (de) * | 1988-09-21 | 1990-03-22 | Scholle Helmut Dr Med | Verwendung eines ginkgo-extraktes |
| DE4030758A1 (de) * | 1990-09-28 | 1992-04-02 | Schwabe Willmar Gmbh & Co | Extrakt aus blaettern von ginkgo biloba, insbesondere zur intravenoesen injektion oder infusion, verfahren zu seiner herstellung und den extrakt enthaltende ampullenpraeparate |
| DE4308443C2 (de) * | 1993-03-17 | 1996-09-19 | Laves Hans Georg | Arzneimittel zur Behandlung von Retrovirusinfektionen |
| FR2754714B1 (fr) * | 1996-10-22 | 1999-01-22 | Roc Sa | Nouvelles utilisations d'extraits de ginkgo biloba pour la preparation de compositions pharmaceutiques,et methode de traitement cosmetique mettant en oeuvre un extrait de ginkgo biloba |
| FR2759371B1 (fr) * | 1997-02-07 | 1999-03-19 | Bio Merieux | Utilisation d'un polypeptide, pour obtenir une composition pour detecter, prevenir ou traiter une maladie degenerative et/ou auto-immune |
| US6030621A (en) * | 1998-03-19 | 2000-02-29 | De Long; Xie | Ginkgo biloba composition, method to prepare the same and uses thereof |
| WO2002011745A1 (en) * | 2000-08-04 | 2002-02-14 | Angiolab, Inc. | Composition containing ginkgo biloba that inhibit angiogenesis and matrix metalloproteinase |
| KR100417172B1 (ko) * | 2000-08-04 | 2004-02-05 | 주식회사 안지오랩 | 은행엽 엑스를 유효성분으로 하는 혈관신생 억제제 |
| FR2911782A1 (fr) * | 2007-01-31 | 2008-08-01 | Jacqueline Martin | Comment guerir du sida avec mentha pulegium et ginkgo biloba |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2117429C3 (de) * | 1971-04-08 | 1982-04-01 | Fa. Dr. Willmar Schwabe, 7500 Karlsruhe | Verfahren zur Herstellung eines Injektions- bzw. Infusionspräparates mit einem Gehalt an einem Wirkstoffgemisch aus den Blättern von Ginkgo biloba |
| FR2518406A1 (fr) * | 1981-12-22 | 1983-06-24 | Prodipharm | Nouveau procede d'obtention de substances vaso-actives extraites de feuilles de ginkgo |
-
1988
- 1988-07-19 FR FR8809738A patent/FR2634380B1/fr not_active Expired - Lifetime
-
1989
- 1989-04-26 EP EP89401191A patent/EP0352146B1/fr not_active Expired - Lifetime
- 1989-04-26 DE DE8989401191T patent/DE68903065T2/de not_active Expired - Fee Related
- 1989-04-26 ES ES89401191T patent/ES2052942T3/es not_active Expired - Lifetime
- 1989-06-22 CA CA000603639A patent/CA1337177C/en not_active Expired - Fee Related
- 1989-07-18 DK DK355089A patent/DK355089A/da not_active Application Discontinuation
- 1989-07-19 JP JP1184843A patent/JPH0278628A/ja active Pending
-
1992
- 1992-12-28 GR GR920403150T patent/GR3006687T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP0352146A1 (fr) | 1990-01-24 |
| EP0352146B1 (fr) | 1992-09-30 |
| DK355089A (da) | 1990-01-20 |
| ES2052942T3 (es) | 1994-07-16 |
| DE68903065D1 (de) | 1992-11-05 |
| DK355089D0 (da) | 1989-07-18 |
| DE68903065T2 (de) | 1993-03-25 |
| GR3006687T3 (enExample) | 1993-06-30 |
| JPH0278628A (ja) | 1990-03-19 |
| FR2634380B1 (fr) | 1990-10-12 |
| FR2634380A1 (fr) | 1990-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Schwartz et al. | Adriamycin and daunorubicin: a comparison of antitumor activities and tissue uptake in mice following immunosuppression | |
| EP0348353B1 (en) | The use of physiologically active substances for the manufacture of drugs for cerebral and neuronal diseases | |
| US4762705A (en) | Cancer therapy with interferon | |
| US5145839A (en) | Pharmaceutical composition and method of use | |
| KR100955973B1 (ko) | 세포 사멸을 조절하는 세포독성인자 | |
| CA1337177C (en) | Bioparyl, a biological regulator, active against various pathologies | |
| Rao et al. | Preliminary investigation of the radiosensitizing activity of guduchi (Tinospora cordifolia) in tumor‐bearing mice | |
| KR20230091178A (ko) | Phy906 추출물, 황금(s) 추출물 또는 이러한 추출물로부터의 화합물을 포함하는 병용 요법을 이용한 항-면역 체크포인트 억제제의 개선된 치료 지수 | |
| KR101734093B1 (ko) | 알러지 유발 물질을 저감시킨 정제 봉독을 유효성분으로 함유하는 염증성 질환 예방 및 치료용 약학적 조성물 | |
| US5151425A (en) | Method of and composition for treating inflammation and the immunological response thereto | |
| CN116286391A (zh) | 链格孢菌的发酵化合物在治疗炎性损伤类疾病中的应用 | |
| US5413787A (en) | Bioparyl, a biological regulator, active against various pathologies | |
| US11371037B1 (en) | Zinc-charged pancreatic enzymes for treatment of cancer and inflammation | |
| JP2003504410A (ja) | 藻類のプロテオグリカン抽出物およびその使用方法 | |
| US7589062B2 (en) | Two synthetic peptides for treatment and prevention of cancers | |
| IL91428A (en) | Bioparyl a biological regulator active against various pathologies | |
| CA2378726A1 (en) | Compositions containing muscle-derived active agents | |
| US5939072A (en) | Herbal composition and method of treating viral infection of the liver | |
| EA002290B1 (ru) | Противоопухолевое средство | |
| US6312737B1 (en) | Method of inducing apoptosis in cancer cells using an extract of Melothria indica Lou | |
| WO2021185292A1 (zh) | 黄耆医药组合物在用于制备增强癌症治疗药物中的用途 | |
| Popov et al. | The antimetastatic and immunomodulating activities of ginseng minor glycosides. | |
| US5929104A (en) | Method for inducing apoptosis of cancer cell | |
| KR20010101065A (ko) | 표고버섯 균사체 추출물 유래의 ｌａｋ 활성증강물질 및이를 함유하는 ｌａｋ 활성증강용 제제 | |
| NL8301934A (nl) | Menselijk leukocyt pepsineachtig enzym, werkwijze voor het bereiden van het enzym, en werkwijze en therapeutisch middel voor het behandelen van allergiekwalen, immuuncomplexziekten en tumoren, in welk middel dit als werkzaam ingredient aanwezig is. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MKLA | Lapsed |